Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000174
-
Shares outstanding
-
55,833,616
-
Total 13F shares
-
15,391,128
-
Share change
-
+15,391,128
-
Total reported value
-
$284,643,000
-
Price per share
-
$18.50
-
Number of holders
-
26
-
Value change
-
+$284,643,000
-
Number of buys
-
26
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) as of Q1 2021
As of 31 Mar 2021,
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,391,128 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., BOXER CAPITAL, LLC, Cormorant Asset Management, LP, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, RTW INVESTMENTS, LP, Farallon Capital Management, L.L.C., and Octagon Capital Advisors LP.
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.